Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursofalk for Gallstone Prevention After Sleeve Gastrectomy
NCT02721862Phase 3Unknown
- Sponsor
- American University of Beirut Medical Center
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in cholelithiasis, sponsored by American University of Beirut Medical Center. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT02721862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02721862.